-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) announced that recently, Guilin Southern Pharmaceutical Co., Ltd., the holding subsidiary of the company, was approved by the State Drug Administration for drug registration of sodium phosphonate injection (hereinafter referred to as “this drug”). The approved indications are for treatment of (1) cytomegalovirus retinitis in AIDS (AIDS) patients, and (2) acyclovir resistant herpes simplex viral mucosal infections in patients with impaired immune function.

Zhitongcaijing·12/10/2025 08:57:05
Listen to the news
Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) announced that recently, Guilin Southern Pharmaceutical Co., Ltd., the holding subsidiary of the company, was approved by the State Drug Administration for drug registration of sodium phosphonate injection (hereinafter referred to as “this drug”). The approved indications are for treatment of (1) cytomegalovirus retinitis in AIDS (AIDS) patients, and (2) acyclovir resistant herpes simplex viral mucosal infections in patients with impaired immune function.